After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns ...
Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...
Food and Drug Administration has warned medical device maker Medline that its syringes used in heart procedures are ...
The company removed the devices from the market in February following complaints of the syringes disconnecting from manifolds ...
An FDA inspection of Medline’s facilities in December 2025 found that the company fell short of certain good manufacturing ...
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Medline Industries, citing serious concerns over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results